RESUMO
We report a titanium indiffused waveguide resonator featuring an integrated electro-optic modulator for cavity length stabilisation that produces close to 5 dB of squeezed light at 1550 nm (2.4 dB directly measured). The resonator is locked on resonance for tens of minutes with 70 mW of SH light incident on the cavity, demonstrating that photorefraction can be mitigated. Squeezed light production concurrent with cavity length stabilisation utilising the integrated EOM is demonstrated. The device demonstrates the suitability of this platform for squeezed light generation in network applications, where stabilisation to the reference field is typically necessary.
RESUMO
We report second harmonic generation from a titanium indiffused lithium niobate waveguide resonator device whose cavity length is locked to the fundamental pump laser using an on-chip phase modulator. The device remains locked for more than 5 minutes, producing more than 80% of the initial second harmonic power. The stability of the system is seen to be limited by DC-drift, a known effect in many lithium niobate systems that include deposited electrodes. The presented device explores the suitability of waveguide resonators in this platform for use in larger integrated networks.
RESUMO
INTRODUCTION: Early assessment of a therapeutic response is a central goal in antidepressant treatment. The present study examined the potential for therapeutic drug monitoring and symptom rating to predict venlafaxine treatment efficacy (measured by overall patient response and remission). METHODS: 88 patients were uptitrated homogenously to 225 mg/day venlafaxine. Serum concentrations of venlafaxine (VEN) and its active metabolite O-desmethylvenlafaxine (ODV) were measured at week 2. Continuous psychopathometric ratings were measured for up to 6 weeks by independent study raters. RESULTS: An early improvement was significantly more common in venlafaxine responders than non-responders (χ(2); p=0.007). While ODV serum levels were significantly higher in responders (t test; p=0.006), VEN serum levels, sum level of VEN+ODV and the ratio of ODV/VEN levels were not. Moreover, patients who showed an early response combined with an ODV serum level above the median of 222 ng/mL were significantly more likely to achieve full response (binary logistic model; p<0.01). Sensitivity (84% for early response) and specificity (81% for combination of early response and therapeutic drug monitoring) were sufficient to qualify as a reasonable screening instrument. CONCLUSION: Our results indicate that early improvement and ODV serum concentration are predictive of therapeutic outcome and can thus be used to guide use of the antidepressant venlafaxine.
Assuntos
Antidepressivos/farmacologia , Antidepressivos/uso terapêutico , Transtorno Depressivo/tratamento farmacológico , Succinato de Desvenlafaxina/farmacologia , Monitoramento de Medicamentos , Cloridrato de Venlafaxina/farmacologia , Cloridrato de Venlafaxina/uso terapêutico , Adulto , Succinato de Desvenlafaxina/sangue , Relação Dose-Resposta a Droga , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Escalas de Graduação Psiquiátrica , Resultado do Tratamento , Cloridrato de Venlafaxina/sangueRESUMO
INTRODUCTION: Current diagnostic classifications regard psychotic symptoms during depressive episodes as indicators of depression severity. However, growing evidence suggests that depression with psychotic symptoms (MDP) may represent a distinct subtype of depression. In the course of the search for discriminating factors we tested the hypothesis that the serotonin transporter gene (5-HTTLPR) may interact with the manifestation of psychotic symptoms in acute depression. METHODS: 112 inpatients (61 female) with a depressive episode (16 bipolar, 86 unipolar) at admission were genotyped for 5-HTTLPR variants. Psychotic symptoms und general psychopathology were evaluated comprehensively using the Manual of the Association for Methodology and Documentation in Psychiatry (Arbeitsgemeinschaft für Methodik und Dokumentation in der Psychiatrie, 1981). For statistical analysis a chi-square test and a logistic regression model was used. RESULTS: 16 (14.3%) out of 112 patients were currently presenting with psychotic symptoms. The primary finding of our study was the higher prevalence of the s-allele of the 5-HTTLPR within the group of MDP patients (Pearson χ²=7.87; df=2; p<0.03). Secondly, in a logistic regression model, 5-HTTLPR was found to significantly contribute to the diagnosis of MDP (χ²=6.5; df=1; p=0.01). This effect was even more pronounced upon comparing only severely depressed patients with MDP patients. From a psychopathological perspective, MDP patients showed higher AMDP hostility and apathy scores but equal AMDP depression scores. DISCUSSION: This is the first study to show an influence of 5-HTTLPR on psychotic symptoms in acutely depressed patients. LIMITATIONS: The lack of a control group and the relatively small sample size limits the present study's findings, thus replication in a larger sample is necessary.
Assuntos
Transtorno Depressivo Maior/genética , Proteínas da Membrana Plasmática de Transporte de Serotonina/genética , Algoritmos , Alelos , Transtorno Depressivo Maior/psicologia , Feminino , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo GenéticoRESUMO
LN photonic wires of cross-section dimensions down to 1 x 0.73 microm2 were fabricated by Ar milling of a single-crystalline LiNbO3 (LN) film bonded to a SiO2/LiNbO3 substrate. Mode intensity distributions, propagation losses, and group indices of refraction were measured at 1.55 microm wavelength and compared with simulation results. Moreover, effective mode indices and end face reflectivities were numerically evaluated. The waveguide of 1 microm top width is the smallest LN photonic wire reported to date; it has a mode size of approximately 0.4 microm2 (0.5 microm2) only and propagation losses of 9.9 dB/cm (12.9 dB/cm) for qTM (qTE) polarization.
Assuntos
Nanoestruturas/química , Nióbio/química , Dispositivos Ópticos , Óxidos/química , Refratometria/instrumentação , Desenho Assistido por Computador , Desenho de Equipamento , Análise de Falha de Equipamento , Teste de Materiais , Nanoestruturas/ultraestrutura , Fótons , Espalhamento de RadiaçãoRESUMO
INTRODUCTION: Because the irreversible monoamine oxidase inhibitor tranylcypromine (TCP) was introduced nearly 50 years ago, only few studies exist on today's clinical prescribing practice together with 2nd and 3rd generation psychotropic drugs. METHODS: We performed a practice-based observational study of patients with depression treated with TCP in two psychiatric departments in Berlin to assess side effects, effectiveness, comedication and acceptance of the low-tyramine diet. RESULTS: We identified thirty-two patients treated with TCP at a mean dose of 51.9 mg/day after an average of 3.3 pre-treatments in the current episode. Dosing of TCP and the use of multiple psychotropic comedications indicate a high-intensity treatment. The most frequent side effects resulted from arterial hypotonia (28%). Dietary restrictions were mainly rated as moderate. 59% of patients remitted (HAMD- (21)<9 or CGI-I=1) and 22% responded (HAMD- (21) reduction >50% or CGI-I=2). DISCUSSION: A high-intensity treatment of inpatients with TCP is clinically feasible, i.e., the use of high doses and multiple comedications with a good benefit-risk-ratio. Prospective data aiming at comparisons with modern antidepressants and clarifying further safety issues are warranted.
Assuntos
Antidepressivos/efeitos adversos , Antidepressivos/uso terapêutico , Transtorno Depressivo/tratamento farmacológico , Inibidores da Monoaminoxidase/efeitos adversos , Inibidores da Monoaminoxidase/uso terapêutico , Tranilcipromina/efeitos adversos , Tranilcipromina/uso terapêutico , Adulto , Idoso , Antidepressivos/administração & dosagem , Terapia Combinada , Transtorno Depressivo/dietoterapia , Transtorno Depressivo/psicologia , Dieta , Interações Medicamentosas , Resistência a Medicamentos , Quimioterapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Inibidores da Monoaminoxidase/administração & dosagem , Escalas de Graduação Psiquiátrica , Estudos Retrospectivos , Tranilcipromina/administração & dosagem , Resultado do Tratamento , Tiramina/fisiologiaRESUMO
High-visibility interference of photon echoes generated in spatially separated solid-state atomic ensembles is demonstrated. The solid-state ensembles were LiNbO(3) waveguides doped with erbium ions absorbing at 1.53 microm. Bright coherent states of light in several temporal modes (up to 3) are stored and retrieved from the optical memories using two-pulse photon echoes. The stored and retrieved optical pulses, when combined at a beam splitter, show almost perfect interference, which demonstrates both phase preserving storage and indistinguishability of photon echoes from separate optical memories. By measuring interference fringes for different storage times, we also show explicitly that the visibility is not limited by atomic decoherence. These results are relevant for novel quantum-repeater architectures with photon-echo based multimode quantum memories.
RESUMO
We investigated the preservation of information encoded into the relative phase and amplitudes of optical pulses during storage and retrieval in an optical memory based on stimulated photon echo. By interfering photon echoes produced in a single-mode Ti:Er:LiNbO(3) waveguide, we found that decoherence in the medium translates only as loss and not as degradation of information. We measured a visibility for interfering echoes close to 100%. These results may have important implications for future long-distance quantum communication protocols.
RESUMO
Mid-infrared radiation near 2.8 mum was generated by difference-frequency generation in an 80-mm-long periodically poled Ti:LiNbO(3) channel waveguide by pump radiation near 1.55 mum (tunable external-cavity laser) and a signal radiation of 3.391 mum (HeNe laser). We obtained a normalized conversion efficiency of 105% W(-1) , which is to our knowledge the highest value ever reported.